Kliničke studije za Глиом u državi Kalifornija
27 studija za Глиом traži učesnike na lokacijama u državi Kalifornija.
Gradovi u državi Kalifornija
Zvanični tekst studije (na engleskom)
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
- UCSD Moores Cancer Center, La Jolla
- Cedars-Sinai Medical Center, Los Angeles
- UC Irvine Health, Orange
- и још 1
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT07326566A Phase I Clinical Study of YN003 in the Treatment of Glioma
- University of California, Los Angeles (UCLA), Los Angeles
- University of California, San Francisco (UCSF), San Francisco
Тражи се учесникФаза 1
Узраст од 18 до 70 · Оба пола · Ажурирано 10. 11. 2026. · NCT07929909Safety and Efficacy Study of Safusidenib in Participants With IDH1-Mutant Glioma Who Discontinued Vorasidenib Treatment Due to Progressive Disease
- University of California, Los Angeles, Los Angeles
- University of California, San Francisco, San Francisco
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 10. 11. 2026. · NCT07703436A Phase 1 Safety and Dose Finding Study of GLIX1 in Adults With Recurrent or Progressive High-grade Glioma
- Stanford University, Palo Alto
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07464925A Study to Test How Well Different Doses of BI 764532 Are Tolerated by People With a Tumour in the Brain That is Positive for DLL3
- University of California Irvine, Orange
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 27. 10. 2026. · NCT05916313Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
- University of California, Irvine, Irvine
- University of California Los Angeles, Los Angeles
- University of California at San Francisco, San Francisco
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 21. 10. 2026. · NCT06810544SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
- University of California San Diego, La Jolla
- University of California, Los Angeles, Los Angeles
- Hoag Memorial Hospital Presbyterian, Newport Beach
- и још 2
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 19. 10. 2026. · NCT05303519Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
- Research Site, Los Angeles
- Research Site, San Francisco
Тражи се учесникФаза 1/2
Узраст од 18 до 130 · Оба пола · Ажурирано 5. 10. 2026. · NCT05417594MCT for the Harvard/UCSF ROBIN Center
- University of California, San Francisco, San Francisco
Тражи се учесник
Сви узрасти · Оба пола · Ажурирано 1. 10. 2026. · NCT06000787A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
- Children's Hospital Los Angeles, Los Angeles
- University of California at Los Angeles, Los Angeles
Тражи се учесникФаза 1/2
До 25 година · Оба пола · Ажурирано 25. 9. 2026. · NCT04094610Trial of Anti-PD-1 Immunotherapy and Stereotactic Radiation in Patients With Recurrent Glioblastoma
- Cedars-Sinai Medical Center, Los Angeles
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 21. 9. 2026. · NCT04977375A Study of the Safety, Dosing, and Delivery of NEO100 in Patients With Pediatric Brain Tumors
- Children's Hospital Orange County (CHOC), Orange
Тражи се учесникФаза 1
Узраст од 5 до 18 · Оба пола · Ажурирано 15. 9. 2026. · NCT06357377Assessing Brain Metabolism Using MRS With Deuterated Glucose
- University of California, San Francisco, San Francisco
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
Узраст 18 и старији · Оба пола · Ажурирано 2. 9. 2026. · NCT06594315Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)
- Children's Hospital Los Angeles, Los Angeles
- University of California, San Diego Rady Children's Hospital, San Diego
- University of California, San Francisco, San Francisco
Тражи се учесникФаза 1
Узраст од 1 до 25 · Оба пола · Ажурирано 18. 8. 2026. · NCT04485559Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies
- UCI Irvine Health, Orange
Тражи се учесникФаза 4
Узраст 18 и старији · Оба пола · Ажурирано 11. 8. 2026. · NCT07486713Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors
- Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange
Тражи се учесникРана фаза 1
Узраст 18 и старији · Оба пола · Ажурирано 31. 7. 2026. · NCT07628634A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- Precision NextGen Oncology & Research Center, Beverly Hills
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
- University of California Los Angeles Rheumatology, Westwood, Los Angeles
Тражи се учесникФаза 2
Узраст 8 и старији · Оба пола · Ажурирано 27. 7. 2026. · NCT05503797Imaging of Solid Tumors Using 18F-TRX
- University of California, San Francisco, San Francisco
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 23. 7. 2026. · NCT06942104Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery
- Stanford University School of Medicine, Palo Alto
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 29. 6. 2026. · NCT03510208Hyperpolarized Imaging in Diagnosing Participants With Glioma
- University of California, San Francisco, San Francisco
Тражи се учесникФаза 1
Узраст 19 и старији · Оба пола · Ажурирано 18. 6. 2026. · NCT03739411Longitudinal Prospective Study of Neurocognition & Neuroimaging in Primary BT Patients
- Moores Cancer Center, San Diego
Тражи се учесникОпсервациона студија
Узраст од 18 до 99 · Оба пола · Ажурирано 10. 6. 2026. · NCT05576103Serial MR Imaging and MR Spectroscopic Imaging for the Characterization of Lower Grade Glioma
- University of California, San Francisco, San Francisco
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 29. 4. 2026. · NCT04540107A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
- UCLA Hematology/Oncology, Westwood, Los Angeles
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 20. 4. 2026. · NCT06326411rHSC-DIPGVax Plus Checkpoint Blockade for the Treatment of Newly Diagnosed DIPG and DMG
- Children's Health Orange County (CHOC), Orange
Тражи се учесникФаза 1
12 Months – 18 Years · Оба пола · Ажурирано 17. 3. 2026. · NCT04943848DB107-RRV, DB107-FC, and Radiation Therapy With or Without Temozolomide (TMZ) for High Grade Glioma
- University of Southern California, Los Angeles
- University of California, San Diego, San Diego
- University of California, San Francisco
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 11. 3. 2026. · NCT06504381Zr-89 Crefmirlimab Berdoxam and Immuno-Positron Emission Tomography for the Imaging of Patients With Resectable Brain Tumors
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 5. 2. 2026. · NCT06650163The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)
- University of California, San Francisco (UCSF), San Francisco
Тражи се учесникОпсервациона студија
Узраст од 18 до 90 · Оба пола · Ажурирано 22. 2. 2024. · NCT06118723Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.